OUTLOOK THERAPEUTICS, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
OUTLOOK THERAPEUTICS, INC. (OTLK) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $6.61 million as of 2025-09-30, per its 10-K filed 2025-12-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2025-12-19
- 2025-09-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $6.61M.
- 2024-09-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $6.46M.
- 2023-09-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $5.07M.
- 2022-09-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $4.33M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-09-30 | $6.61M 10-K · filed 2025-12-19 |
| 2024-09-30 | $6.46M 10-K · filed 2025-12-19 |
| 2023-09-30 | $5.07M 10-K · filed 2024-12-27 |
| 2022-09-30 | $4.33M 10-K · filed 2023-12-22 |
| 2021-09-30 | $2.17M 10-K · filed 2022-12-29 |
| 2020-09-30 | $795.22K 10-K · filed 2021-12-23 |
| 2019-09-30 | $10.58M 10-K · filed 2020-12-23 |
| 2018-09-30 | $10.23M 10-K · filed 2019-12-19 |
| 2017-09-30 | $14.10M 10-K · filed 2018-12-18 |
| 2016-09-30 | $11.25M 10-K · filed 2017-12-29 |
| 2015-09-30 | $6.32M 10-K · filed 2016-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |